Nuvalent Inc (NASDAQ: NUVL) kicked off on Monday, down -6.20% from the previous trading day, before settling in for the closing price of $76.61. Over the past 52 weeks, NUVL has traded in a range of $61.79-$113.51.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded -81.88%. With a float of $42.86 million, this company’s outstanding shares have now reached $65.50 million.
In an organization with 92 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Nuvalent Inc (NUVL) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Nuvalent Inc is 39.68%, while institutional ownership is 65.55%. The most recent insider transaction that took place on Jan 06 ’25, was worth 197,854. In this transaction Chief Scientific Officer of this company sold 2,483 shares at a rate of $79.68, taking the stock ownership to the 59,981 shares. Before that another transaction happened on Jan 06 ’25, when Company’s Chief Development Officer sold 4,016 for $79.68, making the entire transaction worth $320,009. This insider now owns 48,034 shares in total.
Nuvalent Inc (NUVL) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -81.88% per share during the next fiscal year.
Nuvalent Inc (NASDAQ: NUVL) Trading Performance Indicators
Take a look at Nuvalent Inc’s (NUVL) current performance indicators. Last quarter, stock had a quick ratio of 23.07.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.48, a number that is poised to hit -1.08 in the next quarter and is forecasted to reach -4.51 in one year’s time.
Technical Analysis of Nuvalent Inc (NUVL)
Let’s dig in a bit further. During the last 5-days, its volume was 0.57 million. That was better than the volume of 0.56 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 20.91%. Additionally, its Average True Range was 3.35.
During the past 100 days, Nuvalent Inc’s (NUVL) raw stochastic average was set at 5.19%, which indicates a significant decrease from 12.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 35.49% in the past 14 days, which was lower than the 57.43% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $88.25, while its 200-day Moving Average is $82.32. However, in the short run, Nuvalent Inc’s stock first resistance to watch stands at $75.70. Second resistance stands at $79.54. The third major resistance level sits at $82.60. If the price goes on to break the first support level at $68.80, it is likely to go to the next support level at $65.74. The third support level lies at $61.90 if the price breaches the second support level.
Nuvalent Inc (NASDAQ: NUVL) Key Stats
The company with the Market Capitalisation of 5.11 billion has total of 71,053K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -126,220 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -84,350 K.
